Delivery Order SPE2DB22D2206-SPE2DB25FJA66
Award Date 7/23/25
Potential Completion Date 7/24/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $30,266.84 delivery order to AmerisourceBergen Drug Corp for Omnipod 5 Dexcom G7 Generation 5 insulin infusion pods. The order is a firm fixed price, non-set-aside contract with an ultimate completion date of September 15, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,715.24 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin infusion pump pods (Generation 5) with a completion date of August 28, 2025. This non-competed delivery order utilizes firm fixed pricing and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is positioned as a critical vendor...
- The Defense Logistics Agency awarded a $2,395.34 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, issued on July 25, 2025, with an ultimate completion date of July 28, 2025, represents a firm fixed price procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this medical device delivery, which supports the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $2,254.09 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods to be performed in Conshohocken, Pennsylvania. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 5, 2025. As a child order under a larger contract vehicle, this delivery supports the federal government's pharmaceutical and medical supply procurement needs through...
- The Defense Logistics Agency (DLA) awarded a Delivery Order valued at $2,444.64 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 insulin delivery pods (Generation 5), 5-supply packages. This competitively awarded, firm fixed price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025. The products will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $16,496.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The contract, which is a non-set-aside award, represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. Performance will be completed by September 11,...
- The Defense Logistics Agency awarded a delivery order valued at $1,138.73 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin delivery pods. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.30 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Gen 5 insulin infusion pods. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of August 4, 2025. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal medical supply chain requirements. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $6,926.84 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods, with performance at the vendor's Conshohocken, Pennsylvania facility. This firm fixed-price, competitively awarded delivery order is scheduled for completion by May 13, 2025, and represents a continuation of supply support under AmerisourceBergen's broader pharmaceutical distribution mandate for federal medical procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,205.91 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, to be completed by September 10, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...